Klass P E, Klein J O
Department of Pediatrics, Boston University School of Medicine, MA.
Pediatr Infect Dis J. 1992 Sep;11(9):702-5. doi: 10.1097/00006454-199209000-00005.
To determine current opinions among experts in pediatric infectious diseases for treatment of bacterial sepsis, meningitis and acute otitis media, we polled directors of training programs in January, 1992. Responses were received from 69 centers in the United States and Canada. For initial treatment of presumed bacterial meningitis, the third generation cephalosporins alone or combined with ampicillin have become drugs of choice in all age groups. Most infectious disease programs include dexamethasone in the management of presumed bacterial meningitis for children 2 months of age and older. Third generation cephalosporins are also drugs of choice for presumed sepsis: combined with ampicillin for infants 5 weeks of age; used alone for children 5 months and 12 years of age. Amoxicillin remains the preferred drug for initial treatment of acute otitis media. The combination of amoxicillin and clavulanic acid is favored in the setting of an increased proportion of beta-lactamase-producing bacterial pathogens. Comparison of these results with polls in 1987 and 1989 indicates a shift in recommendations of therapy of presumed bacterial sepsis and meningitis from ampicillin alone or combined with an aminoglycoside or chloramphenicol to use of a third generation cephalosporin alone or combined with ampicillin.
为了确定儿科传染病专家对细菌性败血症、脑膜炎和急性中耳炎治疗的当前意见,我们于1992年1月对培训项目主任进行了调查。收到了来自美国和加拿大69个中心的回复。对于疑似细菌性脑膜炎的初始治疗,单独使用第三代头孢菌素或与氨苄西林联合使用已成为所有年龄组的首选药物。大多数传染病项目在对2个月及以上儿童疑似细菌性脑膜炎的治疗中使用地塞米松。第三代头孢菌素也是疑似败血症的首选药物:5周龄婴儿与氨苄西林联合使用;5个月至12岁儿童单独使用。阿莫西林仍然是急性中耳炎初始治疗的首选药物。在产生β-内酰胺酶的细菌病原体比例增加的情况下,阿莫西林和克拉维酸的组合更受青睐。将这些结果与1987年和1989年的调查结果进行比较,表明疑似细菌性败血症和脑膜炎的治疗建议已从单独使用氨苄西林或与氨基糖苷类或氯霉素联合使用转向单独使用第三代头孢菌素或与氨苄西林联合使用。